{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:04:34Z","timestamp":1791925474585,"version":"4.3.4"},"reference-count":42,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Food and Chemical Toxicology"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1016\/j.fct.2008.09.052","type":"journal-article","created":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T05:23:41Z","timestamp":1222838621000},"page":"3732-3738","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["High dose of commercial products of kava (Piper methysticum) markedly enhanced hepatic cytochrome P450 1A1 mRNA expression with liver enlargement in rats"],"prefix":"10.1016","volume":"46","author":[{"given":"Yuko","family":"Yamazaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Hashida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Arita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Hamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumio","family":"Shimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fct.2008.09.052_bib1","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1016\/S0024-3205(02)01555-2","article-title":"Kava\u2013kava and anxiety: growing knowledge about the efficacy and safety","volume":"70","author":"Bilia","year":"2002","journal-title":"Life Sci."},{"key":"10.1016\/j.fct.2008.09.052_bib2","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.etp.2006.08.002","article-title":"Immunohistochemical analysis of expressions of hepatic cytochrome P450 in F344 rats following oral treatment with kava extract","volume":"58","author":"Clayton","year":"2007","journal-title":"Exp. Toxicol. Pathol."},{"key":"10.1016\/j.fct.2008.09.052_bib3","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1136\/bmj.322.7279.139","article-title":"Hepatitis associated with Kava, a herbal remedy for anxiety","volume":"322","author":"Escher","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.fct.2008.09.052_bib4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00213-003-1520-0","article-title":"Extracts of kava (Piper methysticum) induce acute anxiolytic-like behavioral changes in mice","volume":"170","author":"Garrett","year":"2003","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.fct.2008.09.052_bib5","first-page":"131","article-title":"Kava consumption and its health effects","volume":"13","author":"Gounder","year":"2006","journal-title":"Pac. Health Dialog"},{"key":"10.1016\/j.fct.2008.09.052_bib6","series-title":"Principles and Methods of Toxicology","first-page":"609","article-title":"Microsomal enzymes involved in toxicology analysis and separation","author":"Guengerich","year":"1982"},{"key":"10.1016\/j.fct.2008.09.052_bib7","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.clpt.2005.01.009","article-title":"In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4\/5 phenotypes","volume":"77","author":"Gurley","year":"2005","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.fct.2008.09.052_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.200600300","article-title":"Clinical assessment of CYP2D6-mediated herb\u2013drug interactions in humans: Effects of milk thistle, black cohosh, goldenseal, kava kava, St. John\u2019s wort, and Echinacea","author":"Gurley","year":"2008","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.fct.2008.09.052_bib9","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1006\/rtph.1999.1335","article-title":"Background to the ADI\/TDI\/PTWI","volume":"30","author":"Herrman","year":"1999","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.fct.2008.09.052_bib10","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1006\/abio.1993.1239","article-title":"Ethoxyresorufin O-deethylase and porphyrin analysis in chicken embryo hepatocyte cultures with a fluorescence multiwell plate reader","volume":"211","author":"Kennedy","year":"1993","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.fct.2008.09.052_bib11","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1046\/j.1365-2125.1999.00073.x","article-title":"CYP3A4 drug interactions: correlation of 10 in vitro probe substrates","volume":"48","author":"Kenworthy","year":"1999","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.fct.2008.09.052_bib12","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.fct.2008.09.052_bib13","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/toxsci\/kfm035","article-title":"Effects of kava alkaloid, pipermethystine, and kavalactones on oxidative stress and cytochrome P450 in F-344 rats","volume":"97","author":"Lim","year":"2007","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.fct.2008.09.052_bib14","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1080\/03602530701690374","article-title":"Drugs as CYP3A probes, inducers, and inhibitors","volume":"39","author":"Liu","year":"2007","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.fct.2008.09.052_bib15","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2174\/1389200043335397","article-title":"CYP3A4 induction by xenobiotics: biochemistry, experimental methods and impact on drug discovery and development","volume":"5","author":"Luo","year":"2004","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.fct.2008.09.052_bib16","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1124\/dmd.107.015826","article-title":"CYP1A induction and human risk assessment: an evolving tale of in vitro and in vivo studies","volume":"35","author":"Ma","year":"2007","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.fct.2008.09.052_bib17","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1124\/dmd.104.000786","article-title":"Desmethoxyyangonin and dihydromethysticin are two major pharmacological kavalactones with marked activity on the induction of CYP3A23","volume":"32","author":"Ma","year":"2004","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.fct.2008.09.052_bib18","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s002130100792","article-title":"Efficacy of kava\u2013kava in the treatment of non-psychotic anxiety, following pretreatment with benzodiazepines","volume":"157","author":"Malsch","year":"2001","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.fct.2008.09.052_bib19","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1124\/dmd.30.11.1153","article-title":"Inhibition of human cytochrome P450 activities by kava extract and kavalactones","volume":"30","author":"Mathews","year":"2002","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.fct.2008.09.052_bib20","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1124\/dmd.105.004317","article-title":"Pharmacokinetics and disposition of the kavalactone kawain: interaction with kava extract and kavalactones in vivo and in vitro","volume":"33","author":"Mathews","year":"2005","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.fct.2008.09.052_bib21","doi-asserted-by":"crossref","first-page":"23847","DOI":"10.1074\/jbc.R400004200","article-title":"Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer","volume":"279","author":"Nebert","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.fct.2008.09.052_bib22","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0190-9622(94)70142-3","article-title":"Kava dermopathy","volume":"31","author":"Norton","year":"1994","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.fct.2008.09.052_bib23","first-page":"211","article-title":"The poisoning of \u2018awa: the non-traditional use of an ancient remedy","volume":"11","author":"O\u2019Sullivan","year":"2004","journal-title":"Pac. Health Dialog"},{"key":"10.1016\/j.fct.2008.09.052_bib24","first-page":"CD003383","article-title":"Kava extract for treating anxiety","volume":"4","author":"Pittler","year":"2001","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.fct.2008.09.052_bib25","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1124\/dmd.31.5.533","article-title":"Regulation of CYP3A4 expression in human hepatocytes by pharmaceuticals and natural products","volume":"31","author":"Raucy","year":"2003","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.fct.2008.09.052_bib26","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0278-5846(01)00330-X","article-title":"Anxiolytic-like effects of kava\u2013kava in the elevated plus maze test \u2013 a comparison with diazepam","volume":"26","author":"Rex","year":"2002","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.fct.2008.09.052_bib27","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.clpt.2005.01.021","article-title":"Traditional aqueous kava extracts inhibit cytochrome P450 1A2 in humans: protective effect against environmental carcinogens?","volume":"77","author":"Russmann","year":"2005","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.fct.2008.09.052_bib28","first-page":"549","article-title":"Herbal and dietary supplements for treatment of anxiety disorders","volume":"76","author":"Saeed","year":"2007","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.fct.2008.09.052_bib29","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1046\/j.1563-258X.2002.02058.x","article-title":"Piper methysticum (kava) under discussion: observations on quality, effectiveness and safety","volume":"152","author":"Schmidt","year":"2002","journal-title":"Wien Med. Wochenschr."},{"key":"10.1016\/j.fct.2008.09.052_bib30","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1055\/s-2003-40658","article-title":"Aqueous kava extracts do not affect liver function tests in rats","volume":"69","author":"Singh","year":"2003","journal-title":"Planta Med."},{"key":"10.1016\/j.fct.2008.09.052_bib31","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.phymed.2006.01.006","article-title":"Safety of ethanolic kava extract: results of a study of chronic toxicity in rats","volume":"13","author":"Sorrentino","year":"2006","journal-title":"Phytomedicine"},{"key":"10.1016\/j.fct.2008.09.052_bib32","first-page":"420","article-title":"The correlation between cancer incidence and kava consumption","volume":"59","author":"Steiner","year":"2000","journal-title":"Hawaii Med. J."},{"key":"10.1016\/j.fct.2008.09.052_bib33","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0168-8278(03)00175-2","article-title":"Hepatitis induced by Kava (Piper methysticum rhizoma)","volume":"39","author":"Stickel","year":"2003","journal-title":"J. Hepatol."},{"key":"10.1016\/j.fct.2008.09.052_bib34","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0022-3565(25)38136-X","article-title":"Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2","volume":"265","author":"Tassaneeyakul","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.fct.2008.09.052_bib35","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1078\/0944-7113-00314","article-title":"Kava extracts: safety and risks including rare hepatotoxicity","volume":"10","author":"Teschke","year":"2003","journal-title":"Phytomedicine"},{"key":"10.1016\/j.fct.2008.09.052_bib36","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1055\/s-2002-36360","article-title":"Inhibition of cytochrome P450 3A4 by extracts and kavalactones of Piper methysticum (Kava\u2013Kava)","volume":"68","author":"Unger","year":"2002","journal-title":"Planta Med."},{"key":"10.1016\/j.fct.2008.09.052_bib37","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1002\/rcm.1621","article-title":"Simultaneous determination of the inhibitory potency of herbal extracts on the activity of six major cytochrome P450 enzymes using liquid chromatography\/mass spectrometry and automated online extraction","volume":"18","author":"Unger","year":"2004","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.fct.2008.09.052_bib38","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/YCO.0b013e3282f2d814","article-title":"Complementary and alternative medicine in the treatment of anxiety and depression","volume":"21","author":"van der Watt","year":"2008","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.fct.2008.09.052_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-2007-979474","article-title":"Kava\u2013kava extracts WS 1490 versus placebo in anxiety disorders \u2013 a randomized placebo-controlled 25-week outpatient trial","volume":"30","author":"Volz","year":"1997","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.fct.2008.09.052_bib40","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.tiv.2004.10.003","article-title":"Cell-based high-throughput bioassays to assess induction and inhibition of CYP1A enzymes","volume":"19","author":"Yueh","year":"2005","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.fct.2008.09.052_bib41","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0024-3205(02)01913-6","article-title":"Effects of herbal components on cDNA-expressed cytochrome P450 enzyme catalytic activity","volume":"71","author":"Zou","year":"2002","journal-title":"Life Sci."},{"key":"10.1016\/j.fct.2008.09.052_bib42","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1078\/0944711041495263","article-title":"Effects of kava (Kava\u2013kava, \u2018Awa, Yaqona, Piper methysticum) on c-DNA-expressed cytochrome P450 enzymes and human cryopreserved hepatocytes","volume":"11","author":"Zou","year":"2004","journal-title":"Phytomedicine"}],"container-title":["Food and Chemical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278691508005516?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278691508005516?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T20:48:54Z","timestamp":1759524534000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278691508005516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":42,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S0278691508005516"],"URL":"https:\/\/doi.org\/10.1016\/j.fct.2008.09.052","relation":{},"ISSN":["0278-6915"],"issn-type":[{"value":"0278-6915","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High dose of commercial products of kava (Piper methysticum) markedly enhanced hepatic cytochrome P450 1A1 mRNA expression with liver enlargement in rats","name":"articletitle","label":"Article Title"},{"value":"Food and Chemical Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fct.2008.09.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}